Vertex Pharmaceuticals Inc (VRTX)

257.86
-3.98(-1.52%)
  • Volume:
    109,500
  • Day's Range:
    257.29 - 262.08
  • 52 wk Range:
    176.36 - 292.75

VRTX Overview

Prev. Close
261.84
Day's Range
257.29-262.08
Revenue
7.95B
Open
260.59
52 wk Range
176.36-292.75
EPS
9.49
Volume
109,500
Market Cap
66.03B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
1,636,879
P/E Ratio
27.60
Beta
0.55
1-Year Change
21.03%
Shares Outstanding
255,755,961
Next Earnings Date
Jul 27, 2022
What is your sentiment on Vertex?
or
Vote to see community's results!

Vertex Pharmaceuticals Inc News

Vertex Pharmaceuticals Inc Analysis

Vertex Pharmaceuticals Inc Company Profile

Vertex Pharmaceuticals Inc Company Profile

Employees
3400

Vertex Pharmaceuticals Incorporated is a global biotechnology company. The Company is focused on developing medicines that treat the underlying cause of cystic fibrosis (CF) and it has several ongoing clinical and research programs to advance and extend treatment of CF. The Company's marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor) and KALYDECO (ivacaftor). It has a pipeline of investigational therapies in other serious diseases where it is leveraging insight into causal human biology, including sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency, and muscular dystrophies. It offers medicines for people with serious diseases with a focus on specialty markets. The Company's four medicines are being used to treat most of the people with CF in North America, Europe and Australia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellNeutralNeutralStrong BuyStrong Buy
Technical IndicatorsStrong SellSellStrong BuyNeutralStrong Buy
SummaryStrong SellNeutralBuyBuyStrong Buy
  • Thanks for the ride VRTX!
    0
    • New moderna/ more shorts plz =))) --->295
      0
      • Keeps this stock, rotation from tech growth to value stock is coming this year, I expect VRTX will benefit from this.
        1
        • What a priceless tought. Safe money here in this actual cenario...
          0
      • this is a most unexpected though long awaited bump. glad i held
        0
        • finally, it's moving, I'm holding this one from more than a year
          0
          • it's so underpriced
            1
            • was there a stock split last 12 months?
              2
              • Nope?
                0
              • No
                0
            • was there a stock split last 12 months?
              1
              • this is almost half price from peak now
                0
                • this is almost half price from peak now
                  0